<DOC>
	<DOCNO>NCT02195466</DOCNO>
	<brief_summary>Study determine effect single-dose steady-state TPV/RTV 500/200 mg steady-state pharmacokinetics fluconazole</brief_summary>
	<brief_title>Effects Single-dose Steady-state TPV/RTV Steady-state Pharmacokinetics Fluconazole Healthy Adult Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Tipranavir</mesh_term>
	<mesh_term>Fluconazole</mesh_term>
	<criteria>Male female subject 18 60 year age inclusive A Body Mass Index ( BMI ) 18 29 kg/m2 Signed informed consent prior trial participation Ability swallow multiple large capsule without difficulty Acceptable laboratory value indicate adequate baseline organ function require time screen . Laboratory value consider acceptable severity less equal Grade 1 , base AIDS Clinical Trials Group ( ACTG ) Grading Scale . All abnormal laboratory value great Grade 1 subject approval trial clinical monitor Acceptable medical history , physical examination , 12lead electrocardiogram , chest Xray ( conduct within last 12 month deem necessary investigator ) require prior enter treatment phase study Willingness abstain follow start 14 day prior administration study drug end study : Grapefruit grapefruit juice Red wine Seville oranges St. John 's Wort Milk Thistle Willingness abstain alcohol start 2 day prior administration study drug end study Willingness abstain follow within 72 hour pharmacokinetics ( PK ) sampling : Garlic supplement Methylxanthine contain drink ( coffee , tea , cola , energy drink , chocolate , etc . ) Willingness abstain counter herbal medication duration study Have nonsmoker 3 month Willingness abstain vigorous physical exercise intensive PK Days 6 , 7 , 13 Reasonable probability completion study Female subject reproductive potential : Have positive serum βhuman chorionic gonadotropin ( hCG ) Visit 1 , Day 0 Day 1 Have use barrier contraceptive method least 3 month prior Visit 3 ( Day 1 ) Are willing use reliable method barrier contraception ( diaphragm spermicidal cream/jelly condoms spermicidal foam ) , trial 60 day completion/termination Are breastfeed Participation another trial investigational medicine within 60 day prior Day 0 ( Visit 2 ) Use prohibit medication list protocol within 30 day prior Day 0 ( Visit 2 ) Use pharmacological contraceptive ( include oral , patch injectable contraceptive ) within 1 month study initiation duration study . Use DepoProvera exclude six month prior study initiation Use hormone replacement therapy within 1 month study initiation duration study Administration antibiotic within 10 day prior Day 0 ( Visit 2 ) trial History acute illness within past 60 day . Subjects exclude disorder great sixty day , opinion investigator , subject qualify healthy volunteer History thrombotic disease History migraine headache Have serological evidence hepatitis B virus ( HBV ) hepatitis C virus ( HCV ) Have serological evidence exposure HIV Recent history alcohol substance abuse ( within 1 year study period ) Blood plasma donation within 30 day Day 0 ( Visit 2 ) trial Subjects seat systolic blood pressure either &lt; 100 mm Hg &gt; 150 mm Hg ; rest heart rate either &lt; 50 beats/min &gt; 90 beats/min . For subject rest heart rate 50 , 90 , investigator may discuss exclusion medical monitor casebycase basis Subjects history illness allergy , opinion investigator , might confound result study pose additional risk administer TPV , RTV FCZ subject Subjects acute illness within 2 week prior Day 0 ( Visit 2 ) Subjects currently take overthecounter prescription drug within 7 day prior Day 0 ( Visit 2 ) , opinion investigator consultation Boehringer Ingelheim ( Canada ) Ltd./Ltée clinical monitor , might interfere either absorption , distribution metabolism test substance Known hypersensitivity TPV , RTV , FCZ , sulphonamide class drug Inability adhere protocol Cautions warning FCZ package insert , judgment investigator , exclude subject study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>